Phase
Condition
N/ATreatment
InSpace Subacromial Tissue Spacer
Clinical Study ID
Ages > 65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects MUST meet ALL the following criteria to be included in the study:
The subject has signed the IRB approved Informed Consent Form (ICF) specific to thisstudy prior to enrollment
Is male or female ≥ sixty-five (65) years of age
Positive diagnostic imaging by MRI within 9 months of enrollment of the indexshoulder indicating a full thickness MRCT:
Measuring ≥ 5 cm in diameter
Involving ≥ two tendons
Functional deltoid muscle and preserved passive range of motion on physicalexamination
Documented VAS score > 30 mm pain
Failed non-operative treatment of at least 3 months from the initial treatment toinclude one or more of the following:
Oral analgesics
Anti-inflammatory medication (e.g., ibuprofen, naproxen)
Corticosteroid injection(s)
Physical therapy
Activity modification
Rest (sling used)
Must be able to read and understand the approved Informed Consent Form (written andoral)
Must be in general good health (as determined by the Investigator) based onscreening assessments and medical history
Must be independent, ambulatory, and can comply with all post-operative evaluations,visits, and electronic database collection
Intra-operative Inclusion Criteria
Subjects MUST meet the following criteria to be randomized in the study:
Full thickness tear
Tear size ≥ 5 cm in diameter
Tear involving ≥ two tendons
Exclusion
Exclusion Criteria:
Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:
Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)
Evidence of the following conditions:
Severe gleno-humeral or acromio-humeral arthritis
Full thickness cartilage loss as seen on MRI
History within the past 5 years of anterior or posterior shoulder subluxationor dislocation as determined by history, examination, or radiographic findings
Pre-existing deltoid defect or deltoid palsy
Major joint trauma, infection, or necrosis
Partial thickness tears of the supraspinatus
Fully reparable rotator cuff tear [Tear of less than 5 cm in diameter (or < 4cm2) with retractable tendon that can be fully repaired]
Known neurovascular compromise
Complete deltoid muscle palsy
Traumatic muscle tears of the pectoralis or deltoid
The subject requires concomitant:
Subscapularis repair
Labral repair of any type
Biceps tenodesis
Previous surgery of the index shoulder in the past 1 year, excluding diagnosticarthroscopy
The subject's condition is bilateral and rotator cuff repair is scheduled or to bescheduled over the course of this study for the contra lateral shoulder
Major medical condition that could affect quality of life and influence the resultsof the study (e.g., rheumatoid arthritis)
The subject has documented evidence of a history (e.g., liver testing) ofdrug/alcohol abuse within 12 months of enrollment
The subject's condition represents a worker's compensation case
The subject is currently involved in a health-related litigation procedure
Females of child-bearing potential who are pregnant or plan to become pregnant.
Concurrent participation in an investigational clinical study one month prior toenrollment or during the entire study period
The subject is physically or mentally compromised (e.g., currently being treated fora psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extentthat the Investigator judges the subject to be unable or unlikely to remaincompliant to follow-up
The subject is receiving prescription narcotic pain medication for conditionsunrelated to the index shoulder condition
The subject currently has an acute infection in the area surrounding the surgicalsite.
Baseline WORC score less than 420
Intra-operative Exclusion Criteria:
Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:
Rotator cuff is/presents with:
Fully reparable with adequate tissue and muscle quality (equivalent toGoutallier stage 1 or 2)
Partial thickness tear of the supraspinatus
Evidence of significant osteoarthritis
The subject requires concomitant:
Subscapularis repair
Labral repair of any type
Biceps tenodesis
Coracoacromial ligament functional deficiency or shoulder instability is identified
Study Design
Study Description
Connect with a study center
Musculoskeletal-Orthopedic Research and Education Foundation
Phoenix, Arizona 85023
United StatesActive - Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas 72205
United StatesActive - Recruiting
Steadman Hawkins Clinic Denver
Englewood, Colorado 80112
United StatesActive - Recruiting
UC Denver
Englewood, Colorado 80112
United StatesActive - Recruiting
Holy Cross Hospital
Fort Lauderdale, Florida 33308
United StatesActive - Recruiting
Paley Orthopaedics & Spine
West Palm Beach, Florida 33407
United StatesActive - Recruiting
Emory University
Atlanta, Georgia 30329
United StatesActive - Recruiting
Rush University Medical Center
Chicago, Illinois 60612
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 55905
United StatesActive - Recruiting
Hospital for Special Surgery
New York, New York 10021
United StatesActive - Recruiting
The Rothman Institute
Philadelphia, Pennsylvania 19107
United StatesActive - Recruiting
TSAOG Orthopaedics & Spine
San Antonio, Texas 78258
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.